Download Slide Title - WordPress.com

MFHCC Meeting
March 7, 2017
Jefferson County Public Health
Lakewood, CO
Welcome and Introductions
Agenda
• Arrive, sign in, grab lunch
• Welcome & Introductions – Lisa
• Previous Action Items - Lisa
• Agency Updates - All – Janelle
• Updates/Changes to HCCs and Healthcare Preparedness Program (HPP) – Lisa and
•
•
•
•
•
•
•
•
Janelle
Upcoming Training and Events – Lisa and Janelle
Member Agency Spotlight – N/A
Infectious Disease Update: Mumps & Measles – Carol McDonald
Health Alert Network (HAN) Overview – Lisa and Christine
Healthy Jeffco Data Portal – Christine
Inpatient Bed Tracking Discussion – Janelle and Lisa
Review New Action Items – Janelle
Networking
REVIEW PREVIOUS
ACTION ITEMS
Lisa
Review Previous Action Items
Contact Christine/Cali if interested in becoming a JCPH or Denver
Closed POD.
All
On-going
Email Janelle or Lisa to sign up for workgroups of interest,
including the PHED EX workgroup.
All
On-going
Member Spotlight - email Janelle and Lisa if you would like to be
featured on the website.
ALL
ON-GOING
Cali will e-mail the Inventory Management System Excel form to all
Denver Closed POD partners for confirmation and for POD site
records.
Consider writing a letter of support for EMS Bus grant
Cali Zimmerman
TBD
James Robinson
Christine Billings, Alexis
Garcia
Lisa and Janelle
On-going
Christine Billings
DONE
Contact Ginny Schwartzer if interested in participating in a Disaster
Book Club
Ginny Schwartzer
On-going
Contact Karri Knight if interested in participating in exercise at DIA
on July 26, 2017.
Karri Knight
TBD
Contact DIA if interested in serving as evaluator or controller for
the exercise at DIA on July 26, 2017
Ashlee Herring
On-going
Inform North Central Region public health committee about the
need for HazMat/Decon training
Lisa and Janelle
DONE
Provide job postings to Janelle and Lisa
Share updates about HPP/HCC changes
Include sample language regarding review of Emergency
Operations Plan (EOP) in the Minutes
3/10/17
DONE
AGENCY UPDATES
Janelle
Agency Updates
• Please mention brief updates you would like to share with
the entire group
• Include your name and agency name
• High level reports applicable to various agencies
• Updates requiring in depth discussions may transition
into workgroups
Agency Updates
• Epidemiology Update
• Hospitals
• Public/Environmental Health
• EMS Provider
• Emergency Management
• Long Term Care
• Mental/ Behavioral Health
• Outpatient Medical Services (Example: community health center,
clinic, dialysis, etc.)
• Other HCC Partner (Example: education, private, federal entity,
coroner, etc.).
HOSPITAL PREPAREDNESS
PROGRAM (HPP) AND HCC
CHANGES
FY 2017 – 2022
Lisa
Next Steps
• Current plan to be shared at Colorado Healthcare Coalition Council
meeting Friday, March 10th
• Janelle and Lisa will be attending and share info with the MFHCC as
needed
UPCOMING TRAININGS AND
EVENTS
Lisa and Janelle
Networking Event
• Thank you to all who attended Full Moon Snowshoe
Hike/Dinner on February 11th!
• Lisa Filipczak
• Sarah Janci
• Donna Kline
• Karri and Adam Knight (and puppy Annie!)
• Will Moorhead
• Ginny Schwartzer
• Charles Smedly
• Janelle Worthington and Treye McKinney
Upcoming Events & Trainings
Idaho Springs dinner and Mt. Evans/Echo Lake snowshoe hike
MFHCC Website - 2017 Training and
Exercise Opportunities in our Community
• March 8 – Develop an Emergency Action Plan for an Active Shooter
•
•
•
•
•
•
•
•
Event
March 23 – Emergency Preparedness for Aging Populations
March 29 – Closed Point of Dispensing (POD) Workshop by CDPHE
April 12 – Detecting Workplace Violence
Throughout the year - Mental Health First Aid Trainings
May 8 - Trauma Informed Care Workshops, Jefferson Center for
Mental Health
July 25-26 - Public Information in an All-Hazards Incident
Sept. 19-20 - Pediatric Disaster Response and Emergency
Preparedness
Relayed request for PPE/Decontamination/HazMat trainings to
North Central Region
PHED EX
• Public Health Emergency Dispensing Exercise (PHED EX) – June
2017
• Workgroup divided into two groups:
1. Denver PHED EX Workgroup
2. Jefferson/Clear Creek/Gilpin PHED EX Workgroup
• Working on scheduling IMS drill for April or May
• Agency participation – please update or add your agency info to this
spreadsheet
• March 29 – Closed Point of Dispensing (POD) Workshop by CDPHE
• Communications workgroup
• Will meet to review draft plan and eventually test it
Hazard Vulnerability Assessment (HVA)
Tool Trainings
• CDPHE Office of Emergency Preparedness and Response (OEPR)
developed new HVA Tool for partners and stakeholders
• In-person: HVA Tool Training following April 4th MFHCC Meeting,
1:30-3pm, led by Michael Delgado
• All MFHCC partners encouraged to attend
• Please register on CO.train (see email and minutes for details)
• Webinar Options through June 1st: 9:30-11:00AM and 1:30-
3:00PM each Tuesday and Thursday. *Let Lisa & Janelle know if you
participate in a webinar
MEMBER AGENCY
SPOTLIGHT
Lisa
REMEMBER THESE
DISEASES - THEY ARE BACK
MUMPS and MEASLES
Carol McDonald, MSN, RN
Denver Public Health
HISTORY-MEASLES
 9th Century-First accounts published by a Persian physician
 1757-Scottish physician demonstrated that the disease was caused by an
infectious agent in the blood
 1912-became a nationally notifiable disease in the U.S.
 1912-1922-Average of 6,000 measles-related deaths reported annually
 1950’s-nearly all children got the disease by the time they were 15 years old
 1950’s-early 1960’s-Estimated annually that 400-500 people died, 48,000
were hospitalized, and 4,000 suffered encephalitis
 1963-John Enders and colleagues licensed the first measles vaccine in the
U. S.
 1968-An improved vaccine was developed by Maurice Hilleman and
colleagues; it was called the Edmonston-Enders strain, a more attentuated
vaccine
 1971-Combined vaccines debut, MMR
 1989-1991-Outbreaks in the U.S. sickened thousands
 2000-Measles disease was declared eliminated from U.S.
 2008-CDC updated recommendations for administration of MMRV
References:
References: http://www.immunize.org/timeline/ and
http://www.historyofvaccines.org/timeline?timeline_categories[]=51
ABOUT THE DISEASE
Also known as rubeola virus
Highly contagious respiratory infection-90% secondary
attack rate among susceptible persons
Incubation period-usually 8-14 days (range of 7-21 days)
Symptoms
 Usually begins with a high fever, cough, runny nose, red/watery eyes
 2-3 days after the above symptoms, Koplik spots may appear inside
the mouth
 3-5 days after symptoms begin, a flat/red rash appears usually on the
face at the hairline and spreads downward to the
neck/trunk/arms/legs/feet. Small raised bumps may appear on top
of the flat red spots. Coalescing of the rash may occur as it spreads
from the head and down the body.
 For disease control purposes, consider cases infectious 4 days before
rash onset through 5 days of rash (count rash onset as day 0)
COMPLICATIONS
Estimated that 30% of reported cases have one or more
complications
Complications are more common among children <5 years
of age and adults >20 years of age
Young children-diarrhea, otitis media, croup, and pneumonia
Acute encephalitis can occur in 1 out of every 1000 cases
Death can occur predominately due to respiratory and
neurological complications, 1-3 out of every 1000 cases
DIAGNOSIS
LABSome false-positive results occur even with modern lab tests
Restrict testing to those most likely to have the disease
(fever AND generalized maculopapular rash)
Blood , urine, nasopharyngeal aspirates or throat swabs
Investigate ALL measles reports IMMEDIATELY
Establish a diagnosis
Get vaccination history
Obtain detail of case(s) activity
Notification of risk to exposure
Exclusion until 4 days after rash onset (day of onset counted
as day 0)
CONTACTS-MEASLES
Main purpose of identification is to determine susceptibility
to disease and provide information about PEP
MMR vaccine or Immune Globulin
PEP has to occur within 72 hours of exposure
Non-immune contacts that can’t receive PEP within 72 hours
may be quarantined at home from the 7th through the 21st day
following exposure
If exposure occurs or involves a school(s), all susceptible
students and staff that don’t receive PEP or lack proof of
immunity will be excluded (until 21 days after the onset of rash
in the last reported case)
No specific antiviral treatment is available.
HISTORY-MUMPS
5th Century-Hippocrates wrote about the symptoms
1790-First detailed scientific description by Robert
Hamilton
1913-Two French physicians tried to transmit mumps from
humans to monkeys but this failed
1921-Another scientist transmitted saliva from mumps
patients into cats
1934-Discovered by Ernest W. Goodpasture and Claude D.
Johnson
1948-First effective vaccine created by John Enders and was
used from 1950-1978
1967-Vaccine became available
1971-MMR vaccine became available
ABOUT MUMPS
Viral disease also know as epidemic parotitis
Caused by the Rubulavirus
Characterized by swelling and tenderness of one or more of
the salivary glands, usually the parotid gland(s)
Not all cases of parotitis are due to mumps infection
SYMPTOMS
Symptoms of body aches, loss of appetite, fatigue, headache,
and low-grad fever may occur several days prior to salivary
gland swelling
Adults have a higher risk for complications
Aseptic meningitis-headache and stiff neck
Severe complications are rare but can include: arthritis,
encephalitis, inflammation of the thyroid, mastitis,
inflammation of the kidneys, myocarditis, oophoritis,
pancreatitis, sterility, and hearing impairment
 Exposure to infection during 1st trimester of pregnancy is
associated with an increased risk of spontaneous abortion
OTHER INFORMATION
Transmitted by direct contact with respiratory droplets or
saliva. Can be spread by freshly contaminated fomites.
Average incubation period is 16-18 days with a range of 1225 days
For disease investigation purposes, consider cases infectious
2 days prior to salivary gland swelling through 6 days of
swelling
Outbreaks-factor contributing is being in a crowded
environment
Disease occurring in fully vaccinated individuals
DIAGNOSTICS
Clinical diagnosis may not be reliable
 Blood specimen and buccal swab collection
CONTACTS
Identify household and other close contacts
Case’s activities
Evidence of immunity
 Vaccination history
 Lab evidence
 Birth before 1957
 Documentation of physician –diagnosed mumps
There is no specific treatment or PEP for mumps infection
Public Health intervention-EDUCATION
CASE COUNTS-MUMPS
Questions?
Contact:
Carol McDonald, MSN, RN
Denver Public Health
[email protected]
303-602-3626
• To report an illness or suspected outbreak in Denver:
Call: (303) 602-3614
Email: [email protected]
HEALTH ALERT NETWORK
(HAN) OVERVIEW
Christine Billings and Lisa Filipczak
Health Alert Network (HAN)
HEALTHY JEFFCO DATA
PORTAL
Christine Billings
Healthy Jeffco Data Portal
http://www.healthyjeffco.com/dataportal
INPATIENT BED
TRACKING DISCUSSION
Lisa and Janelle
Inpatient Bed Discussion
• How do you currently report and share information on bed
availability?
• Would inpatient bed capacity information be helpful to share and
know? Why and when?
• How would we collect and share that information?
Review New Action Items
Lisa
Thank you!
Networking